Uridine triphosphate (tetrasodium)
Uridine triphosphate (tetrasodium) (UTP (tetrasodium) ) is released during cardiac ischemia. Uridine triphosphate (tetrasodium) belongs to a family of extracellular nucleotide signaling molecules. Uridine triphosphate (tetrasodium) can stimulate vasodilation, automaticity in ventricular myocytes and release tussue-quantitative activator (t-PA) . Uridine triphosphate (tetrasodium) -induced t-PA release can dissolve the thrombus in myocardial infarction[1].
Product Specifications
CAS Number
14264-46-1
Product Name Alternative
UTP (tetrasodium) ; Uridine 5'-triphosphate (tetrasodium)
UNSPSC
12352005
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Cardiovascular Disease
Smiles
O[C@H]1[C@@H](O)[C@H](N2C=CC(NC2=O)=O)O[C@@H]1COP(OP(OP(O[Na])(O[Na])=O)(O[Na])=O)(O[Na])=O
Molecular Formula
C9H11N2Na4O15P3
Molecular Weight
572.07
References & Citations
[1]Erlinge D, et al., Uridine triphosphate (UTP) is released during cardiac ischemia. Int J Cardiol. 2005 Apr 28;100 (3) :427-33.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Pmel17 / gp100 / SILV (NKI-beteb), CF640R conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (45M1), CF405S conjugate, 0.1mg/mL
C1QA / Complement C1q A-Chain (C1QA/2783), CF647 conjugate, 0.1mg/mL
CD66 (CEA) (C66/1030), CF405S conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), Biotin conjugate, 0.1mg/mL
